Zobrazeno 1 - 10
of 137
pro vyhledávání: '"IBS, irritable bowel syndrome"'
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
IntroductionIrritable bowel syndrome and fibromyalgia share similar pathophysiologic mechanisms including sensitization of peripheral and central pain pathways, autonomic dysfunction and are often co-diagnosed. Co-diagnosed patients experience increa
Externí odkaz:
https://doaj.org/article/a3b8be8a0a46488ca7b2540e6d31323a
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
BackgroundImpaired intestinal permeability and microbial dysbiosis are important pathophysiological mechanisms underlying irritable bowel syndrome (IBS). ReFerm®, also called Profermin®, is a postbiotic product of oat gruel fermented with Lactobaci
Externí odkaz:
https://doaj.org/article/027f577235b04e7691b135d97ec644f0
Autor:
Shreyas V. Kumbhare, Patricia A. Francis-Lyon, Dashyanng Kachru, Tejaswini Uday, Carmel Irudayanathan, Karthik M. Muthukumar, Roshni R. Ricchetti, Simitha Singh-Rambiritch, Juan Ugalde, Parambir S. Dulai, Daniel E. Almonacid, Ranjan Sinha
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Diet and lifestyle-related illnesses including functional gastrointestinal disorders (FGIDs) and obesity are rapidly emerging health issues worldwide. Research has focused on addressing FGIDs via in-person cognitive-behavioral therapies, diet modulat
Externí odkaz:
https://doaj.org/article/097a466f0e964eacb1bdce26742f7e4e
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 14, Pp 1391-1400 (2020)
Rebecca Liu,1 Kyle Staller1,2 1Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; 2Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Bosto
Externí odkaz:
https://doaj.org/article/485cef101a7c4fd59dd4bf0f2b14c69b
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal disorder with a worldwide prevalence of 11%. It is characterized by abdominal pain and altered bowel habits in the absence of underlying unique pathology. The condition
Externí odkaz:
https://doaj.org/article/c59a60e4713243fd80e56d7e40381381
The interplay between stress and fullness in patients with functional dyspepsia and healthy controls
Autor:
Fabienne G M Smeets, Freddy J. Troost, Joanna W. Kruimel, Tim Klaassen, Lisa Vork, Carsten Leue, Ad A.M. Masclee, Daniel Keszthelyi
Publikováno v:
Psychosomatic Medicine, 84(3), 306-312. LIPPINCOTT WILLIAMS & WILKINS
Objective Fullness is a cardinal symptom in functional dyspepsia (FD). The use of real-time symptom assessment might provide more insight into factors, such as daily stress, that can influence fullness. Therefore, this study aimed to use the experien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d76478f69b8a863b01f88df7f7495a0
https://doi.org/10.1097/PSY.0000000000001012
https://doi.org/10.1097/PSY.0000000000001012
Autor:
Ellen A. Lipstein, Jean C. Fox
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 2, Pp 183-189 (2020)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
This article reviews the current uses of shared decision making in gastroenterology and discusses additional areas of opportunity for shared decision making, especially in the area of functional gastrointestinal disorders. PubMed, MEDLINE, and Cochra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acb914f38e005a6d8e71d9c6ddfcb3d0
http://www.sciencedirect.com/science/article/pii/S2542454819301766
http://www.sciencedirect.com/science/article/pii/S2542454819301766
Autor:
Hanna Yaroslavivna Stupnytska, Michael Ivanovich Sheremet, Yuliya Vyacheslavivna Bilooka, Vyacheslav Vasilievich Bilookyi, Oleksandr V. Bilookyi, Pharmacy, Bucharest, Romania, Yurii Yevgenovych Rogovyi, O.I. Fediv, Valentin Nicolae Varlas
Publikováno v:
Journal of Medicine and Life
Investigation of the mechanisms promoting the development of irritable bowel syndrome (IBS) in obese patients is one of the most important issues of modern medicine. We examined 97 patients suffering from IBS. The group of comparison included 10 indi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2b2294f3d2307209b4b9ab4f92cb4d1
http://europepmc.org/articles/PMC8485386
http://europepmc.org/articles/PMC8485386
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nicolas Esquerre, Dominique Bihan, Alana Schick, Yasmin Nasser, Manon Defaye, Fernando A. Vicentini, Lilian Basso, Keith A. Sharkey, Christophe Altier, Simon A. Hirota, Ian A. Lewis, Nina L. Cluny, Humberto Jijon, Markus B. Geuking
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology, Vol 10, Iss 2, Pp 225-244 (2020)
Cellular and Molecular Gastroenterology and Hepatology, Vol 10, Iss 2, Pp 225-244 (2020)
Background & Aims Despite achieving endoscopic remission, more than 20% of inflammatory bowel disease patients experience chronic abdominal pain. These patients have increased rectal transient receptor potential vanilloid-1 receptor (TRPV1) expressio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed1dcda8afaf3b78c0b7073da88d285f
http://europepmc.org/articles/PMC7301239
http://europepmc.org/articles/PMC7301239